← Leaderboards
Susan L Rosenthal
Children'S Hospital Med Ctr (Cincinnati)
$5,013,124
Attributed
$5,013,124
Total exposure
9
Grants
6
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $564.7K · FY2005–15$1M$750K$500K$250K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
Funding mix
By agency
NIH$5,013,124 · 9
By mechanism
R01$4,781,092 · 2
M01$232,032 · 7
Top collaborators
No co-investigators on record.
Most similar at Children'S Hospital Med Ctr (Cincinnati)
Same institution · by research overlap
- Betsy C. Herold$27,491,366
Others in their field
Top investigators on “Sexually Transmitted Diseases”
- Wafaa M. El-Sadr · Columbia University Health Sciences$122,097,913
- Sten H Vermund · University Of Alabama At Birmingham$117,633,913
- Myron S Cohen · Family Health International$108,412,263
- Barton F Haynes · Duke University$107,675,530
- Taha E Taha · Johns Hopkins University$89,821,106
- Willard Cates · Family Health International$66,963,584
Research focus
Sexually Transmitted DiseasesSex BehaviorClinical ResearchVaginaFemaleBehavioral /Social Science Research TagHuman SubjectAdolescence (12-20)AdultMale AdolescentsLeadHouseholdAntiinfective AgentsInfectionHealth BehaviorMother Child InteractionAdolescenceContraceptivesParticipantChemopreventionInterviewCognitionDecision MakingCommunicable Disease Control
Grant awards (19)
Adolescent and Parental Attitudes About STI Prevention Trial Participation$537,193
R01 · FY2015 · HD · contact PI
Adolescent and Parental Attitudes About STI Prevention Trial Participation$564,653
R01 · FY2014 · HD · contact PI
Adolescent and Parental Attitudes About STI Prevention Trial Participation$547,750
R01 · FY2013 · HD · contact PI
Adolescent and Parental Attitudes About STI Prevention Trial Participation$551,291
R01 · FY2012 · HD · contact PI
Adolescent and Parental Attitudes About STI Prevention Trial Participation$551,383
R01 · FY2011 · HD · contact PI
EVALUATION OF OPTICAL COHERENCE TOMOGRAPHY (OCT) AS A SAFETY TOOL FOR ASSESSMENT$2,745
M01 · FY2009 · RR · contact PI
SEROPREVALENCE AND PROSPECTIVE RISK FACTOR ANALYSIS OF CYTOMEGALOVIRUS (CMV)$267
M01 · FY2009 · RR · contact PI
SEROPREVALENCE AND PROSPECTIVE RISK FACTOR ANALYSIS OF CYTOMEGALOVIRUS (CMV)$9,936
M01 · FY2008 · RR · contact PI
SEROPREVALENCE AND PROSPECTIVE RISK FACTOR ANALYSIS OF CYTOMEGALOVIRUS (CMV)$33,274
M01 · FY2007 · RR · contact PI
THE DIARY STUDY$19,826
M01 · FY2006 · RR · contact PI
THE DIARY STUDY$90,405
M01 · FY2005 · RR
MICROBICIDES: DEVELOPMENTAL CONTEXT OF ACCEPTABILITY$407,950
R01 · FY2004 · HD
THE DIARY STUDY$18,499
M01 · FY2004 · RR
MICROBICIDES: DEVELOPMENTAL CONTEXT OF ACCEPTABILITY$396,248
R01 · FY2003 · HD
MICROBICIDES: DEVELOPMENTAL CONTEXT OF ACCEPTABILITY$386,344
R01 · FY2002 · HD
MICROBICIDES: DEVELOPMENTAL CONTEXT OF ACCEPTABILITY$428,159
R01 · FY2001 · HD
ADOLESCENT DEVELOPMENT AND STD ACQUISITION IN FEMALES$28,540
M01 · FY2001 · RR
MICROBICIDES: DEVELOPMENTAL CONTEXT OF ACCEPTABILITY$410,121
R01 · FY2000 · HD
ADOLESCENT DEVELOPMENT AND STD ACQUISITION IN FEMALES$28,540
M01 · FY2000 · RR